儿童中心静脉导管相关的血栓形成性及感染性并发症的预防和治疗

2022-01-07 华中科技大学同济医学院附属同济医院儿童血液科 中国生育健康杂志

中心静脉导管是儿科治疗的重要组成部分,可用于患儿药物、全肠外营养液、血制品等静脉输注及血液透析和血浆置换。

中文标题:

儿童中心静脉导管相关的血栓形成性及感染性并发症的预防和治疗

发布日期:

2022-01-07

简要介绍:

中心静脉导管是儿科治疗的重要组成部分,可用于患儿药物、全肠外营养液、血制品等静脉输注及血液透析和血浆置换。随着中心静脉导管使用率明显增加,静脉导管相关血栓和中心导管相关性血流感染等相关并发症发生率也逐年增加,不仅缩短了静脉导管的使用寿命,也降低了患儿的生活质量,制定适合儿童的预防及治疗方法已引起临床重视。本研究综述了儿童中心静脉导管相关血栓及感染并发症的危险因素、预防和治疗措施。

相关资料下载:
[AttachmentFileName(sort=1, fileName=儿童中心静脉导管相关的血栓形成性及感染性并发症的预防和治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b5aa21c0023221a0, title=儿童中心静脉导管相关的血栓形成性及感染性并发症的预防和治疗, enTitle=, guiderFrom=中国生育健康杂志, authorId=0, author=, summary=中心静脉导管是儿科治疗的重要组成部分,可用于患儿药物、全肠外营养液、血制品等静脉输注及血液透析和血浆置换。, cover=https://img.medsci.cn/2022116/1642338352606_5579292.png, journalId=0, articlesId=null, associationId=2301, associationName=华中科技大学同济医学院附属同济医院儿童血液科, associationIntro=华中科技大学同济医学院附属同济医院儿童血液科 , copyright=0, guiderPublishedTime=Fri Jan 07 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">中心静脉导管是儿科治疗的重要组成部分,可用于患儿药物、全肠外营养液、血制品等静脉输注及血液透析和血浆置换。随着中心静脉导管使用率明显增加,静脉导管相关血栓和中心导管相关性血流感染等相关并发症发生率也逐年增加,不仅缩短了静脉导管的使用寿命,也降低了患儿的生活质量,制定适合儿童的预防及治疗方法已引起临床重视。本研究综述了儿童中心静脉导管相关血栓及感染并发症的危险因素、预防和治疗措施。</span></p>, tagList=[TagDto(tagId=2387, tagName=中心静脉导管), TagDto(tagId=121603, tagName=静脉导管相关血栓), TagDto(tagId=121604, tagName=中心导管相关性血流感染)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=32172, appHits=160, showAppHits=0, pcHits=364, showPcHits=32011, likes=1, shares=20, comments=5, approvalStatus=1, publishedTime=Sun Jan 16 21:00:20 CST 2022, publishedTimeString=2022-01-07, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Jan 16 21:02:13 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 16:19:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=儿童中心静脉导管相关的血栓形成性及感染性并发症的预防和治疗.pdf)])
儿童中心静脉导管相关的血栓形成性及感染性并发症的预防和治疗.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2205531, encodeId=031b220553183, content=怎么看全文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ecb9303963, createdName=ms3000000363325251, createdTime=Sun May 19 19:48:51 CST 2024, time=2024-05-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1186866, encodeId=c9f611868668b, content=有学习到一些东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04f34719062, createdName=2018755032, createdTime=Fri Jan 21 16:31:52 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186565, encodeId=5130118656595, content=要预防血栓形成, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/4e06e234dc414a70b34bb04d3b72196b.jpg, createdBy=4ea72246892, createdName=12157a75m71暂无昵称, createdTime=Thu Jan 20 19:56:00 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185087, encodeId=47dc118508ee4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Jan 17 08:16:37 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2024-05-19 ms3000000363325251 来自广东省

    怎么看全文

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2205531, encodeId=031b220553183, content=怎么看全文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ecb9303963, createdName=ms3000000363325251, createdTime=Sun May 19 19:48:51 CST 2024, time=2024-05-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1186866, encodeId=c9f611868668b, content=有学习到一些东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04f34719062, createdName=2018755032, createdTime=Fri Jan 21 16:31:52 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186565, encodeId=5130118656595, content=要预防血栓形成, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/4e06e234dc414a70b34bb04d3b72196b.jpg, createdBy=4ea72246892, createdName=12157a75m71暂无昵称, createdTime=Thu Jan 20 19:56:00 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185087, encodeId=47dc118508ee4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Jan 17 08:16:37 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-21 2018755032

    有学习到一些东西

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2205531, encodeId=031b220553183, content=怎么看全文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ecb9303963, createdName=ms3000000363325251, createdTime=Sun May 19 19:48:51 CST 2024, time=2024-05-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1186866, encodeId=c9f611868668b, content=有学习到一些东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04f34719062, createdName=2018755032, createdTime=Fri Jan 21 16:31:52 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186565, encodeId=5130118656595, content=要预防血栓形成, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/4e06e234dc414a70b34bb04d3b72196b.jpg, createdBy=4ea72246892, createdName=12157a75m71暂无昵称, createdTime=Thu Jan 20 19:56:00 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185087, encodeId=47dc118508ee4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Jan 17 08:16:37 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-20 12157a75m71暂无昵称

    要预防血栓形成

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2205531, encodeId=031b220553183, content=怎么看全文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ecb9303963, createdName=ms3000000363325251, createdTime=Sun May 19 19:48:51 CST 2024, time=2024-05-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1186866, encodeId=c9f611868668b, content=有学习到一些东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04f34719062, createdName=2018755032, createdTime=Fri Jan 21 16:31:52 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186565, encodeId=5130118656595, content=要预防血栓形成, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/4e06e234dc414a70b34bb04d3b72196b.jpg, createdBy=4ea72246892, createdName=12157a75m71暂无昵称, createdTime=Thu Jan 20 19:56:00 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185087, encodeId=47dc118508ee4, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Jan 17 08:16:37 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-17 微探

    学习学习

    0